Keith A. Betts
Impact in
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
-
- Potassium and Related Disorders 11
- Oncology 22
- Cancer Immunotherapy and Biomarkers 13
- Co-authors
- Eric Q. Wu (22 shared papers)James Signorovitch (15 shared papers)Avani Joshi (10 shared papers)April W. Armstrong (6 shared papers)Paul Hodgkins (5 shared papers)Jipan Xie (5 shared papers)Vanja Sikirica (4 shared papers)M. Haim Erder (4 shared papers)
- Journals
- Advances in Therapy (9 papers)Value in Health (9 papers)Current Medical Research and Opinion (8 papers)Journal of Clinical Oncology (7 papers)Annals of the Rheumatic Diseases (5 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Keith A. Betts
122 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 106
- Immunology 486
- Hematology 242
- Rheumatology 282
- Dermatology 123
- Pulmonary and Respiratory Medicine 339
Countries citing papers authored by Keith A. Betts
This map shows the geographic impact of Keith A. Betts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith A. Betts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith A. Betts more than expected).
Fields of papers citing papers by Keith A. Betts
This network shows the impact of papers produced by Keith A. Betts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith A. Betts. The network helps show where Keith A. Betts may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith A. Betts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 326 | |
| 2 | 2020 | 201 | |
| 3 | 2018 | 100 | |
| 4 | 2021 | 95 | |
| 5 | 2018 | 71 | |
| 6 | 2017 | 59 | |
| 7 | 2014 | 58 | |
| 8 | 2017 | 56 | |
| 9 | 2015 | 50 | |
| 10 | 2021 | 48 | |
| 11 | 2021 | 45 | |
| 12 | 2020 | 44 | |
| 13 | 2011 | 43 | |
| 14 | 2020 | 36 | |
| 15 | 2021 | 32 | |
| 16 | 2022 | 28 | |
| 17 | 2008 | 27 | |
| 18 | 2017 | 27 | |
| 19 | 2017 | 26 | |
| 20 | 2018 | 26 |
About Keith A. Betts
Keith A. Betts is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Epidemiology and Immunology, having authored 133 papers that have together received 2.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Potassium and Related Disorders (11 papers), Psoriasis: Treatment and Pathogenesis (11 papers), Spondyloarthritis Studies and Treatments (9 papers), Economic and Financial Impacts of Cancer (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Inflammatory Bowel Disease (6 papers). The work is most often cited by research in Immunology (486 citations), Hematology (242 citations), Rheumatology (282 citations), Dermatology (123 citations) and Pulmonary and Respiratory Medicine (339 citations). Keith A. Betts has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Eric Q. Wu, James Signorovitch, Avani Joshi, April W. Armstrong, Paul Hodgkins, Jipan Xie, Vanja Sikirica, M. Haim Erder, Fan Mu and Mei Lü. Their work appears in journals such as Advances in Therapy, Value in Health, Current Medical Research and Opinion, Journal of Clinical Oncology and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.